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I. DIMOPOULOU, M. DAGANOU, 0. K. TSINTZAS AND G. E. TZELEPIS 
Pulmonary Function Laboratory, Onassis Cardiac Surgery Center, Athens, Greece 
To investigate the effects of severity of long-standing congestive heart failure (CHF) on pulmonary function, we 
studied 53 (47 men) consecutive patients, all heart transplant candidates. Their mean (*SD) age and ejection 
fraction were 47 +.12 years and 23 i: 7%, respectively. All patients underwent spirometry, lung volume, diffusion 
capacity (DLCO), maximum inspiratory (Prmax) and expiratory pressure (Pnmax) measurement. Maximum 
cardiopulmonary exercise test on a treadmill was also performed to determine maximum oxygen consumption 
( pO,max). On the basis of $‘O,max, the patients were then divided into those with a ?O,max > 14 ml min- ’ kg - i 
(group 1, n= 30) and those with a ?O,max < 14 ml min - ’ kg ~ i (group 2, n=23). In comparison with group 1, 
group 2 patients had lower F&i/FVC (70 * 8% vs 75 f 7%, P=O.OOS), lower FEF,,-,, (46 I-t 21 vs 70 + 26%pred, 
P<O.OOl), lower TLC (76 & 15 vs 85 + 13%pred, P=O.O2) and lower Prmax (68 & 20 vs 87 f 22 cmH,O, P=O.O03), 
but comparable DLCO (84 & 15 vs 88 & 20%pred, P=N.S.), and PEmax (99 i 25 vs 96 & 22 cmH,O, P=N.S.): In 
conclusion, our data suggest that respiratory abnormalities, such as restrictive defects, airway obstruction, and 
inspiratory muscle weakness, are more pronounced in patients with severe CHF than in those with mild-to-moderate 
disease. Further studies are required to investigate the extent to which these abnormalities contribute to dyspnoea 
during daily activities in patients with heart failure. 
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Introduction 
In patients with congestive heart failure (CHF), maximum 
oxygen consumption ( pO,max), as measured during 
cardiopulmonary exercise protocols, is widely accepted as 
the best objective means to quantitate disease severity (1). 
In particular, it has been shown that ?O,max values below 
14ml min-l kg-i are associated with marked cardiac 
dysfunction and therefore this cut-off is currently used to 
assess urgency of cardiac transplantation (2). Furthermore, 
pulmonary function abnormalities, such as restriction, 
obstruction, diffusion impairment (3,4) and respiratory 
muscle weakness (5) have all been well documented in 
long-standing CHF. However, little is known about the 
impact of severity and progression of heart failure on 
pulmonary function abnormalities. 
Accordingly, the current study was designed to investi- 
gate potential differences in respiratory impairment 
between patients with mild-to-moderate CHF, i.e. with 
a PO,max >14 ml min ~ i kg-’ and those with severe 
disease, i.e. with a -i/o,max < 14 ml min - i kg- ‘. 
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Methods 
PATIENT POPULATION 
Fifty-three (47 men) consecutive patients with stable 
CHF, who were evaluated for cardiac transplantation, 
were included. All patients had had heart failure for at 
least 6 months prior to the study, and were receiving 
diuretics (all patients), angiotensin-converting enzymes 
inhibitors (91%), digitalis (87%) nitrates (25%) or calcium 
channel blockers (15%). The average age was 47 & 12 
years (range 1669 years) and the left ventricular ejection 
fraction (LVEF); as measured by angiography, was 
23 + 7% (range 1040%). Thirty-eight patients were ex- or 
current smokers and 15 had never smoked. None of the 
patients were on bronchodilators. According to cardiac 
catheterization, heart failure was attributed to idiopathic 
dilated cardiomyopathy in 25 patients, coronary artery 
disease in 22, and valvular heart disease in six 
patients (one with aortic regurgitation, two with mitral 
regurgitation and three with aortic and mitral regurgi- 
tation). Eight patients had undergone prior coronary 
artery bypass surgery and six patients prior valve replace- 
ment Of the 53 patients, 39 were in sinus rhythm, 12 in 
chronic atria1 fibrillation and two had a permanent 
pacemaker. 
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PROTOCOL 
Cardiopulmonary exercise testing 
All patients underwent a symptom-limited incremental 
cardiopulmonary exercise testing on a treadmill 
(MARQUETTE 2000, Marquette Electronics Inc.) using 
the standardized exponential exercise protocol (STEEP) 
Dargie (6). A 1Zlead ECG was obtained every minute to 
monitor myocardial ischaemia or ventricular arrhythmias 
and arterial blood pressure was monitored every 3 min with 
a cuff sphygmomanometer. The average PO, value 
obtained during the last 60 s of the test was considered as 
?O,max. On -the basis of pO,max attained, heart failure , 
patients were divided into those with! a, VO,max >14 ml 
mint kgg’ (group 1) and those with a kO,max < 14 ml 
min - !. kg - ’ (group 2). 
* i 
Pulmonary fun2fion tests - respiratory muscle strength 
(RMS) assessment 
On a separate day, standard-pulmonary function tests were 
measured with a Jaeger system (Masterlab, Jaeger GmbH & 
CoKG Wuerzberg, Germany). Forced vital capacity 
(FVC), forced expiratory volume in 1 s (FEV,) and maxi- 
mal midexpiratory flow rate (FEF,,-,,) were expressed as 
percent predicted (%pred) (7). Total lung capacity (TLC) 
was determined by the helium dilution method. Both TLC 
and single-breath diffusion capacity for carbon monoxide 
(DLCO) were expressed as %pred (8,9). RMS was assessed 
by measuring maximum static inspiratory (PImax) and 
expiratory pressure (Pnmax) at functional residual capacity 
(FRC) and TLC, respectively; both pressures were 
expressed in cmH,O (10). A light pressure was applied to 
the cheeks during expiratory manoeuvres, to minimize 
contribution of facial muscles (11). Repeated efforts were 
made until the two highest values agreed within 10% and 
the highest value maintained for at least 1 s was used in the 
analysis. 
The present study was approved by the Institutional 
Review Board. 
TABLE 1. Pulmonary function data of all heart failure 
patients (n = 53) 
STATISTICAL ANALYSIS 
Comparison of grouped data was performed by using 
unpaired t-test, ,Mann-Whitney,, Fisher exact, or chi- 
squared analysis, where appropriate. Correlation coeffi- 
cients were calculated by using univariate linear regression 
analysis. All data are expressed as mean&s~ and signifi- 
cance was considered present when PcO.05. 
Results 
For the entire group of CHF patients the mean peak PO, 
was 16&5mlmin-‘kg-’ (range 8-30mlmin-1 kg-‘). 
Pulmonary function data are listed in Table 1. There were 
30 patients in group 1 (mean ?OZmax= 19 * 4 ml min ~ ’ 
kg-‘), and 23 patients in group 2 (mean pO,max= 
12+2mlmin~’ kg ~ ‘). The two groups were well matched 
# Mean f SD 
FVC (%pred) 
FEV, (%pred) 
FEV,IFVC (%) 
FEF,,-,, (%pred) 
TLC (%pred) 
FRC (%pred) 
RV (%pred) 
DLCO (%pred) 
Prmax (cmH,O) 
PEmax (cmH,O) 
92* 17 
88 f 18 
73 Zt7 
60 + 27 
81& 15 
87 zt 21 
go*35 
87& 18 
79 * 22 
97 -f 23 
FVC, forced vital capacity; FEV,, forced expiratory 
volume in 1 s; FEF,,-,,, maximal midexpiratory flow 
rate; TLC, total lung capacity; FRC, functional residual 
capacity; RV, residual volume; DLCO, diffusion capacity 
for carbon monoxide; PLmax, maximum inspiratory 
pressure; PEmax, maximum expiratory pressure. 
for age, gender, weight, height, smoking habits, ejection 
fraction, and type of disease (Table 2). Echocardiographic 
measurements of left atria1 (LA) dimensions were available 
in 44 patients and as displayed in Table 2, group 1 patients 
had significantly lower LA diameter (47 f 8 mm vs 
56 * 9 mm, P<O.OOl). In comparison with group 1, group 2 
had lower FVC, FEV,, FEV,/FVC, FEF,,_,,, TLC, IC or 
Prmax, but similar FRC, DLCO, or PEmax (Table 3). 
For the entire group of CHF patients, mean LA diameter 
(51 + 9 mm) correlated negatively with FEV, (P= - 0.39, 
P=O.O09) or FEF,,-,, (Y= - 0.34, P=O.O2). Similarly, in 
the entire group of patients, vO,max correlated positively 
with FVC %pred (~~0.36, P=O.OOS), FEV, %pred (rz0.46, 
P<O.OOl), FEV,/FVC % (r=0.34, P=O.Ol), FEF,,-,, 
%pred (r=0.46, P<O.OOl) or PImax cmH,O (r=0.48, 
P<O.OOl); in contrast, pO,max did not correlate with TLC, 
D&O, or timax. 
Discussion 
In the present study, we graded severity of CHF according 
to eO,max, and found that patients with marked (cO,max 
2 14 ml min- i kg- ‘) cardiac dysfunction had more 
prominent restriction, airflow limitation and inspiratory 
muscle weakness, than patients with mild-to-moderate 
disease (kO,max > 14 ml min - r kg ~ ‘). 
Various pulmonary function abnormalities have been 
described in CHF patients, including restriction, obstruc- 
tion, diffusion impairment (isolated or combined), and 
several mechanisms by which heart failure affects lung 
function have been proposed (3,4). In addition to these 
abnormalities, respiratory muscle weakness has invariably 
been reported in these patients (5,12). However, corre- 
lations of severity of heart failure with lung dysfunction 
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TABLE 2. Patient characteristics according to severity of heart failure 
Group 1 Group 2 
(?O,max > 14 ml (PO,max 414 ml 
min-’ kg- ‘) min-’ kg-‘) P-value 
Age years* 
Gender (M/F) (71) 
Smokers (n) 
Pack-years (71)* 
Weight (kg)“! 
Height (cm)* 
Ejection fra&ion (%)* 
Type of disease 
CAD (n) 
IDM (71) 
VHD (72) 
LA diameter (mm)* 
45zt13 
28/2 
20 
231klO 
77ztl5 
168.%7 
23 f 6 
‘,lO 
18 
2 
47*7 
51ck9 
1914 
18 
25+8 
78i13 
17Ok9 
23 zt9 
12 
I 
4 
53+9 
N.S. 
N.S. 
N.S. 
N.S. 
.#S. 
N.S. 
N.S. 
N.S. 
<t?,OOl 
$‘O,max, maximum oxygen consumption; CAD; coronary artery disease; IDM, idiopathic dilated 
myocardiopathy; VHD, valvular’heart disease; LA, left atrial. 
*Mean * SD. 
TABLE 3. Pulmonary function data aocqrding to severity of heart failure* 
r  Group 1 
(i/O,max > 14 ml 
min-’ kg-‘) 
Group 2 
(?O,max 4 14 ml 
min-’ kg-‘) P-value 
FVC (%pred) 
FEV, (%pred) 
FEVJFVC (%) 
FEF,,-,, (%pred) 
TLC (%pred) 
FRC (%pred) 
IC (%pred) 
RV (%pred) 
DLCO (%pred) 
Prmax (cmH,O) 
Pnmax (cmH,O) 
_.. 
961t17 
951tl6 
75It7 
70*26 
85% 13,. 
90*20 
831k20 
96h38 
88&20 
87k22 
96k22 
86xbl5 
79+15 
7Odc8 
46zk21 
76xk15 
83*24 
7Ok 19 
82i31 
84*15 
68dz20 
99*25 
0.01 
<O.OOl 
0.008 
<O.OOl 
0.02 
N.S. 
0.03 
N.S. 
N.S. 
0,003 
N.S. 
IC, inspiratory capacity. 
*For remaining abbreviations see Table 1 
have not been extensively investigated and the results are 
contradictory. Usin’g t,he New York Heart Association 
(NYHA) classification as an index of severity of CHF, 
Ambrosino’et al. found that NYHA class III patients had 
lower values for TLC: YC, or Prmax,,than NYHA class II 
patients, but similar DLCO, FEV,/FVC, FEF,,-,, or 
PEmax values (13). It should’be pointed-out, however, that 
NYHA classification re$resents ‘the physican’s subjective 
interpretation of the patient’s report of exercise limitation. 
In addition, there is clinical evidence that although class IV 
patients are well categorized, discrimination between classes 
II and III, which represent the bulk of patients seeking 
medical care; is more difficult (14). In another study, Ries 
et al. graded heart failure according to pulmonary capillary 
wedge pressure (PCWP) and found that patients with 
PCWP valuesexceeding 20 mmHg had lower FVC, FEV, 
and TLC, but&mparable FEV,IFVC and FEF,,-,,. This 
led them to conclude that airway obstruction was not 
significant in patients with marked cardiac dysfunction 
(15). Subsequent studies found no correlations between 
PCWP and lung volumes and it was suggested that restric- 
tion was not related to severity of underlying cardiac 
disease (3;4). 1 
Although NYHA classification and PCWP measurement 
may provide some indication of the functional state of heart 
failure patients, maximum exercise capacity, as assessed by 
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?O,max, is considered the gold standard in ranking sever- 
ity of CHF. Indeed, a peak PO, of less than 14 ml min ~ ’ 
kg-’ is the best discriminatory variable for predicting 
death in such patients (2). Using similar peak PO, values to 
categorize CHF, we noticed that patients with severe dis- 
ease had similar LVEF with those with mild-to-moderate 
CHF. This finding is in agreement with previous data 
indicating poor association between resting indices of ven- 
tricular function and exercise capacity (16). In our study, 
patients attaining a pO,max below 14 ml min - ’ kg - i had 
lower TLC than those with mild disease and this was largely 
due to lower inspiratory capacity (IC). The lower IC is 
probably related to displacement of gas-containing alveoli 
by cardiomegaly, and to increase in lung water, manifested 
as interstitial oedema or pleural effusions (17). These abnor- 
malities are expected to be more pronounced in patients 
with severe disease, who in addition are unable to generate 
sufficient inspiratory force, as indicated by lower Prmax 
values. Nishimura et al. confirmed inspiratory muscle 
weakness in CHF and furthermore they demonstrated a 
correlation of PImax and cardiac index (18). It should be 
underlined however, that changes in lung volumes can 
influence respiratory pressures due to length-tension 
properties of the respiratory muscles (19) and therefore, 
additional studies are needed to clarify the extent to 
which weak muscles significantly contribute to restrictive 
ventilatory defects in CHF. 
Our study demonstrated that airway function was also 
more impaired in patients with severe heart failure than in 
those with mild or moderate disease. This could not be 
accounted for by differences in smoking habits, as the two 
patient groups were matched for smoking history and none 
of the patients were receiving bronchodilators. Although- 
there is agreement that obstruction frequently occurs in 
acute cardiac decompensation (20,21) or after myocardial 
infarction (22) controversy exists concerning the presence 
of airway narrowing in chronic heart failure. Some studies 
reported obstruction in a minority of patients with CHF 
(3,4), while a recent review article stated that airflow 
limitation is a feature of both acute and chronic heart 
failure (23). From a pathophysiological viewpoint, chronic 
CHF is associated with interstitial oedema and changes in 
the peripheral bronchovascular sheats; vascular engorge- 
ment at this level increases the pressure in the interstitial 
space, thereby lowering its stretching effect on airways and 
increasing resistance to flow in distal airways. Moreover, 
the increase in left atria1 pressure, especially in presence of 
high right atria1 pressure, alters bronchial circulation, 
resulting in draining of bronchial blood into the systemic 
circulation instead of into the pulmonary veins and leading 
thus to bronchial mucosal congestion and airway narrow- 
ing (24). Small airways are initially affected, but in more 
severe cases reduction of flows in the large airways may 
also occur. 
In conclusion, our data suggest that patients with 
advanced heart failure and limited capacity to exercise have 
greater impairment in respiratory function than pafients 
with mild-to-moderate disease. The contribution of these 
abnormalities to pathogenesis of dyspnoea and exercise’ 
intolerance rema,i,ns to be determined. 
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